Similar efficacy for ovarian ablation compared with cyclophosphamide, methotrexate, and fluorouracil:From a randomized comparison of premenopausal patients with node-positive, hormone receptor-positive breast cancer

Authors :: Ejlertsen, B.
Mouridsen, H.T.
Jensen, M.B.
Bengtsson, N.O.
Bergh, J.
Cold, S.
Edlund, P.
Ewertz, M.K.
de Graaf, P.W.
Kamby, C.
Nielsen, D.L.
Source :: Ejlertsen, B, Mouridsen, H T, Jensen, M B, Bengtsson, N O, Bergh, J, Cold, S, Edlund, P, Ewertz, M K, de Graaf, P W, Kamby, C & Nielsen, D L 2006, ' Similar efficacy for ovarian ablation compared with cyclophosphamide, methotrexate, and fluorouracil : From a randomized comparison of premenopausal patients with node-positive, hormone receptor-positive breast cancer ', Journal of Clinical Oncology, vol. 24, no. 31, pp. 4956-62 .
Publication Year :: 2006

Language :: English
Database :: OpenAIRE
Journal :: Ejlertsen, B, Mouridsen, H T, Jensen, M B, Bengtsson, N O, Bergh, J, Cold, S, Edlund, P, Ewertz, M K, de Graaf, P W, Kamby, C & Nielsen, D L 2006, ' Similar efficacy for ovarian ablation compared with cyclophosphamide, methotrexate, and fluorouracil : From a randomized comparison of premenopausal patients with node-positive, hormone receptor-positive breast cancer ', Journal of Clinical Oncology, vol. 24, no. 31, pp. 4956-62 .
Accession number :: edsair.pure.au.......5544c46b38d8f63059bc5cc726a14b52

Tools